Drug intelligence / Profile preview

Jing Fang Bai Du San

Development stage
Phase 4
Lead developer
Tianjiang Pharmaceutical
Administration
Oral
01

Overview

Jing Fang Bai Du San is a classical traditional Chinese medicine (TCM) herbal formula composed of 13 herbs. It is primarily used to treat external wind-cold-dampness syndromes manifesting as fever and chills without sweating, headache, body aches, neck stiffness, cough due to lung-cold or dampness accumulation, early-stage abscesses or sores with redness and swelling. The formula works by inducing sweating (to release the exterior), dispelling wind (to counteract pathogenic influences), alleviating pain, transforming phlegm/mucus, harmonizing the body's surface defenses (wei qi), and supporting recovery from acute respiratory infections. Modern pharmacological studies suggest that its main active ingredients include acacetin, wogonin, and isorhamnetin; network pharmacology analyses indicate potential modulation of targets such as EGFR (epidermal growth factor receptor), PIK3CA (phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha), LCK (lymphocyte-specific protein tyrosine kinase), MAPK1/3/8 (mitogen-activated protein kinases), STAT3 (signal transducer and activator of transcription 3), TNF (tumor necrosis factor), IL2 (interleukin-2) and RELA. These mechanisms may underlie its anti-inflammatory effects in conditions like common cold/influenza or even COVID-19[4][5][7]. The formula does not target a single molecular pathway but acts through multi-component synergy typical for TCM formulas.

Brand names
Jing Fang Bai Du San
Other names
Schizonepeta and Saposhnikovia Powder to Overcome Pathogenic InfluencesSchizonepeta and Ledebouriella CombinationSchizonepeta and Siler FormulaAntiphlogistic Powder of Schizonepeta and LedebouriellaChing Fang Pai Tu SanJing Fang Bai Du Wan
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)LCK (Proto-oncogene tyrosine-protein kinase Lck)RELA (Nuclear Factor Kappa B Subunit p65)JNK (Mitogen-activated protein kinase kinase kinase family)PIK3CA (Phosphoinositide 3-kinase alpha)EGFR T790M (Epidermal growth factor receptor T790M mutant)MAPK3 (Mitogen-activated protein kinase 1)IL-2 (Interleukin 2)

Beyond the preview

Go deeper on Jing Fang Bai Du San.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jing Fang Bai Du San.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call